Regulatory Press Releases

Revenue in the second quarter was negatively affected by COVID-19 and decreased by 20.4 percent compared to the same quarter previous year. Revenue amounted to 29.3 MSEK (36.8). The operating profit decreased to -1.5 MSEK (5.1) and was negatively impacted by items affecting comparability of 5.4 MSEK following depreciation of stock and a weakened US dollar. Simultaneously, the operating profit was positively...

Stille has appointed Niklas Carlén as the new CFO for the company and a member of the group management. Niklas Carlén has a Masters Degree of Science in Business Administration and Economics from Örebro University. He has for the past 15 years worked as a CFO at Calix, Swecon and TOOLS Sverige, most recently as the CFO at Eskilstuna Strängnäs Energi och Miljö. I am...

The otherwise often stable business area Surgical Instruments grew by 8 percent compared to previous year, mostly attributed to increased sales in the US. While the quarter started off strong, sales were negatively affected in March due to market realignment from surgery to intensive care. Together, this amounted to a revenue of 36.8 MSEK for the first quarter. It is great to see the progress made...

As an effect of the intensified spread of the COVID-19 virus and the subsequent uncertainty in the market, the board has decided to postpone the annual general meeting and withdraw its earlier proposal on dividends of 1.70 SEK per share. We are monitoring the situation closely in all active markets and evaluating what consequences the pandemic may have on Stille. By postponing the annual general meeting...

Stille AB (publ) today publishes the Annual Report for 2019. Stille’s Annual Report for the business year of 2019 is today being published on the company website www.stille.se. The Annual Report 2019 can also be found in full as an attachment to this press release. Torshälla, March 31st 2020. For more information, please contact: Hanna Ernestam Wilkman CEO Telephone: +46 (0)72 402 10 88...